Your browser doesn't support javascript.
loading
Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial.
Seibold, James R; Maher, Toby M; Highland, Kristin B; Assassi, Shervin; Azuma, Arata; Hummers, Laura Kathleen; Costabel, Ulrich; von Wangenheim, Ute; Kohlbrenner, Veronika; Gahlemann, Martina; Alves, Margarida; Distler, Oliver.
Afiliación
  • Seibold JR; Scleroderma Research Consultants, LLC, Aiken, South Carolina, USA jamesrseibold@gmail.com.
  • Maher TM; National Heart and Lung Institute, Imperial College London, London, UK.
  • Highland KB; National Institute for Health Research Clinical Research Facility, Royal Brompton Hospital, London, UK.
  • Assassi S; Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Azuma A; Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Hummers LK; University of Texas Houston Medical School, Houston, Texas, USA.
  • Costabel U; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
  • von Wangenheim U; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Kohlbrenner V; Interstitial and Rare Lung Disease Unit, Department of Pneumology, Ruhrlandklinik, University Hospital Essen, Essen, Germany.
  • Gahlemann M; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
  • Alves M; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA.
  • Distler O; Boehringer Ingelheim (Schweiz) GmbH, Basel, Switzerland.
Ann Rheum Dis ; 79(11): 1478-1484, 2020 11.
Article en En | MEDLINE | ID: mdl-32759258

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Enfermedades Pulmonares Intersticiales / Inhibidores de Proteínas Quinasas / Indoles Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Enfermedades Pulmonares Intersticiales / Inhibidores de Proteínas Quinasas / Indoles Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos